Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2011 (2011), Article ID 275758, 7 pages
http://dx.doi.org/10.1155/2011/275758
Research Article

Impact of Histopathological Diagnosis with Ancillary Immunohistochemical Studies on Lung Cancer Subtypes Incidence and Survival: A Population-Based Study

1Ticino Cancer Registry, Institute of Pathology, 6600 Locarno, Switzerland
2Division of Clinical Pathology, Institute of Pathology, 6600 Locarno, Switzerland

Received 26 September 2011; Accepted 7 November 2011

Academic Editor: Carmen J. Marsit

Copyright © 2011 Andrea Bordoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H.-R. Shin, F. Bray, and D. Forman, GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 10, International Agency for Research on Cancer, Lyon, France, 2008.
  2. B. L. Egleston, S. I. Meireles, D. B. Flieder, and M. L. Clapper, “Population-Based Trends in Lung Cancer Incidence in Women,” Seminars in Oncology, vol. 36, no. 6, pp. 506–515, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. J. Langer, B. Besse, A. Gualberto, E. Brambilla, and J.-C. Soria, “The evolving role of histology in the management of advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 28, no. 36, pp. 5311–5320, 2011. View at Publisher · View at Google Scholar · View at PubMed
  4. W. D. Travis, E. Brambilla, M. Noguchi et al., “International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 6, no. 2, pp. 244–285, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. G. Rossi, G. Pelosi, P. Graziano, M. Barbareschi, and M. Papotti, “Review article: a reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments,” International Journal of Surgical Pathology, vol. 17, no. 3, pp. 206–218, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. Wu, B. Wang, J. Gil et al., “p63 and TTF-1 immunostaining: a useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung,” American Journal of Clinical Pathology, vol. 119, no. 5, pp. 696–702, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. Y. Wang, J. Gil, D. Kaufman, L. Gan, D. S. Kohtz, and D. E. Burstein, “p63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors,” Human Pathology, vol. 33, no. 9, pp. 921–926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. A. Harlamert, “Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma,” Acta Cytologica, vol. 42, no. 6, pp. 1382–1388, 1998. View at Google Scholar · View at Scopus
  9. N. G. Ordóñez, “Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas,” Advances in Anatomic Pathology, vol. 7, no. 2, pp. 123–127, 2000. View at Google Scholar · View at Scopus
  10. P. A. Bejarano, R. P. Baughman, P. W. Biddinger et al., “Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas,” Modern Pathology, vol. 9, no. 4, pp. 445–452, 1996. View at Google Scholar · View at Scopus
  11. E. C. McLean, H. Monaghan, D. M. Salter, and W. A. Wallace, “Evaluation of adjunct immunohistochemistry on reporting patterns of non-small cell lung carcinoma diagnosed histologically in a regional pathology centre,” Journal of Clinical Pathology, vol. 64, no. 12, pp. 1136–1138, 2011. View at Google Scholar
  12. A. G. Nicholson, D. Gonzalez, P. Shah et al., “Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of Mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis,” Journal of Thoracic Oncology, vol. 5, no. 4, pp. 436–441, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Mukhopadhyay and A. L. A. Katzenstein, “Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6,” American Journal of Surgical Pathology, vol. 35, no. 1, pp. 15–25, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Bordoni, A. Spitale, and P. Mazzola, “Ticino Cancer Registry,” 2009, http://www.ti.ch/cancer.
  15. A. Fritz, A. Jack, D. M. Parkin et al., International Classification of Diseases for Oncology, World Health Organization, Geneva, Switzerland, 3rd edition, 2000.
  16. W. D. Travis, E. Brambilla, and C. C. Harris, Pathology and Genetics of Tumours of the Lung, Pleura,Thymus and Heart, World Health Organization, Lyon, France, 2004.
  17. G. Wagner, Tumor-Lokalisationsschlüssel: International Classification of Diseases for Oncology ICD-O, 2. Topographischer Teil, Springer, Berlin, Germany, 5th edition, 1993.
  18. O. M. Jensen, D. M. Parkin, R. MacLennan, C. S. Muir, and R. G. Skeet, Cancer Registration: Principles and Methods, IARC Scientific Publication No. 95, IARC, Lyon, France, 1991.
  19. J. E. Tyczynski, E. Démaret, and D. M. Parkin, Standards and Guidelines for Cancer Registration in Europe. The ENCR Recommendations, vol. 1 of IARC Technical Publication n.40, IARC, Lyon, France, 2003.
  20. D. M. Parkin, V. W. Chen, J. Ferlay, J. Galceran, H. H. Storm, and S. L. Whelan, “Comparability and quality control in cancer registration,” IARC Technical Report No 19, IARC, Lyon, France, 2004. View at Google Scholar
  21. I. D. Fleming, J. S. Cooper, D. E. Henson et al., AJCC Cancer Staging Manual, Lippincott-Raven, Philadelphia, Pa, USA, 5th edition, 1997.
  22. F. L. Greene, D. L. Page, I. D. Fleming et al., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 6th edition, 2002.
  23. J. Esteve, E. Benhamou, and L. Raymond, Statistical Methods in Cancer Research, vol. 4 of IARC Scientific Publications, World Health Organisation, Lyon, France, 2004.
  24. D. Kleinbaum, L. Kupper, and K. Muller, Applied Regression Analysis and Other Multivariable Methods, Duxbury Press, North Scituate, Mass, USA, 1988.
  25. “Statistical Research and Applications Branch and National Cancer Institute,” Joinpoint Regression Program, Version 3.0., 2005.
  26. H. J. Kim, M. P. Fay, E. J. Feuer, and D. N. Midthune, “Permutation tests for joinpoint regression with applications to cancer rates,” Statistics in Medicine, vol. 19, no. 3, pp. 335–351, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Charloux, E. Quoix, N. Wolkove, D. Small, G. Pauli, and H. Kreisman, “The increasing incidence of lung adenocarcinoma: Reality or artefact? A review of the epidemiology of lung adenocarcinoma,” International Journal of Epidemiology, vol. 26, no. 1, pp. 14–23, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. M. L. G. Janssen-Heijnen and J. W. W. Coebergh, “The changing epidemiology of lung cancer in Europe,” Lung Cancer, vol. 41, no. 3, pp. 245–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. S. Devesa, F. Bray, A. P. Vizcaino, and D. M. Parkin, “International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising,” International Journal of Cancer, vol. 117, no. 2, pp. 294–299, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. J. Thun, C. A. Lally, J. T. Flannery, E. E. Calle, W. D. Flanders, and C. W. Heath, “Cigarette smoking and changes in the histopathology of lung cancer,” Journal of the National Cancer Institute, vol. 89, no. 21, pp. 1580–1586, 1997. View at Google Scholar · View at Scopus
  31. S. D. Stellman, J. E. Muscat, S. Thompson, D. Hoffmann, and E. L. Wynder, “Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking,” Cancer, vol. 80, no. 3, pp. 382–388, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Righi, P. Graziano, A. Fornari et al., “Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation,” Cancer, vol. 117, no. 15, pp. 3416–3423, 2011. View at Publisher · View at Google Scholar · View at PubMed
  33. N. Rekhtman, D. C. Ang, C. S. Sima, W. D. Travis, and A. L. Moreira, “Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens,” Modern Pathology, vol. 24, no. 10, pp. 1348–1359, 2011. View at Publisher · View at Google Scholar · View at PubMed
  34. G. Pelosi, G. Rossi, F. Bianchi et al., “Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens,” Journal of Thoracic Oncology, vol. 6, no. 6, pp. 1039–1049, 2011. View at Google Scholar
  35. A. Kargi, D. Gurel, and B. Tuna, “The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas,” Applied Immunohistochemistry and Molecular Morphology, vol. 15, no. 4, pp. 415–420, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus